Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
TACTILE SYSTEMS TECHNOLOGY INC (TCMD) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 8-K Quarterly results
08/07/2023 8-K Quarterly results
Docs: "Assets Current assets Cash and cash equivalents $ 63,212 $ 21,929 Accounts receivable 46,553 54,826 Net investment in leases 13,219 16,130 Inventories 20,315 23,124 Income taxes receivable 1,779 — Prepaid expenses and other current assets 4,480 3,754 Total current assets 149,558 119,763 Non-current assets Property and equipment, net 5,771 6,077 Right of use operating lease assets 20,041 21,322 Intangible assets, net 48,559 50,375 Goodwill 31,063 31,063 Accounts receivable, non-current 15,430 23,061 Other non-current assets 3,306 3,335 Total non-current assets 124,170 135,233 Total assets $ 273,728 $ 254,996 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 9,296 $ 9,984 Note payable 2,968 2,968 Earn-out, current 9,280 13,050 Accrued payroll and related taxes 13,80..."
07/18/2023 8-K Quarterly results
05/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/08/2023 8-K Quarterly results
Docs: "First Quarter Revenue Increased 23% Year-Over-Year MINNEAPOLIS, MN, May 8, 2023 – Tactile Systems Technology, Inc. , a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2023. First Quarter 2023 Summary: ● Total revenue increased 23% year-over-year to $58.8 million ● Lymphedema products revenue increased 22% year-over-year ● Airway clearance products revenue increased 24% year-over-year ● Operating loss of $3.8 million versus $14.9 million in Q1 2022 ● Non-GAAP operating loss of $2.2 million versus $5.4 million in Q1 2022 ● Net loss of $1.9 million versus $15.6 million in Q1 2022 ● Adjusted EBITDA of $0.5 million versus a $2.6 million loss in Q1 20..."
03/14/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Offer Letter between Elaine M. Birkemeyer and Tactile Systems Technology, Inc.",
"Tactile Medical Appoints Elaine Birkemeyer as Chief Financial Officer"
02/28/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement, between the Company and William Blair & Company, L.L.C., as the underwriter",
"Opinion of Faegre Drinker Biddle & Reath LLP",
"Tactile Systems Technology, Inc. Announces Proposed Public Offering of Common Stock MINNEAPOLIS, Minn.——Feb. 23, 2023— Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. Tactile Medical intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the offering at the public offering price, less the underwriting discounts and commissions. All of the shares of common stock to be sold in the proposed offering will be sold by Tactile Medical. The offering is subject to market and other conditions, ...",
"Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock MINNEAPOLIS, Minn.—— Feb. 23, 2023— Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $13.00 per share. The gross proceeds to Tactile Medical from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be $32.5 million. Additionally, Tactile Medical has granted the underwriter a 30-day option to purchase up to an additional 375,000 shares of its common stock at the public o..."
01/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Tactile Medical Appoints Carmen Volkart to Board of Directors"
12/23/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "TACTILE SYSTEMS TECHNOLOGY, INC. AMENDED AND RESTATED BY - LAWS Effective: March 10, 2021 December 19, 2022 Article I OFFICES Section 1.1              REGISTERED OFFICE . The Corporation shall maintain a registered office and registered agent within the State of Delaware at such place within such State as may be designated from time to time by the B b oard of D d irectors of the Corporation. Section 1.2              OTHER OFFICES . The Corporation may also have offices in such other places, either within or without the State of Delaware, as the B b oard of D d irectors may from time to time designate or the business of the Corporation m..."
11/29/2022 8-K Quarterly results
11/07/2022 8-K Quarterly results
Docs: "Third Quarter Revenue Increased 24% Year-Over-Year; First Nine Months Revenue Increased 18% Year-Over-Year MINNEAPOLIS, MN, November 7, 2022 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the third quarter and nine months ended September 30, 2022. Third Quarter 2022 Summary: ● Total revenue increased 24% year-over-year to $65.3 million, compared to $52.5 million in third quarter 2021. ● Total revenue in third quarter 2022 included $11.0 million of revenue from sales of airway clearance products, which includes the AffloVest product line acquired on September 8, 2021, compared to $0.9 million of revenue in third qu..."
08/01/2022 8-K Quarterly results
Docs: "Second Quarter Revenue Increased 17% Year-Over-Year; First Half Revenue Increased 15% Year-Over-Year MINNEAPOLIS, MN, August 1, 2022 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the second quarter and six months ended June 30, 2022. Second Quarter 2022 Summary: ● Total revenue increased 17% year-over-year to $59.6 million, compared to $51.1 million in second quarter 2021. ● Total revenue in second quarter 2022 included $8.0 million of revenue from sales of airway clearance products, which includes the AffloVest product line acquired on September 8, 2021. ● Operating loss of $4.1 million, compared to $0.1 m..."
05/10/2022 8-K Quarterly results
05/02/2022 8-K Quarterly results
02/22/2022 8-K Quarterly results
Docs: "Fourth Quarter Revenue Increased 4% Year-Over-Year; Full Year Revenue Increased 11% Year-over-Year MINNEAPOLIS, MN, February 22, 2022 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 Summary: ● Total revenue increased 4% year-over-year to $61.7 million, compared to $59.2 million in fourth quarter 2020. ● Total revenue in fourth quarter 2021 included $4.3 million of revenue from the AffloVest respiratory therapy business, acquired on September 8, 2021. ● Operating income of $3.8 million, compared to operating income of $7.0 million in..."
02/22/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Tactile Medical Announces Qui Tam Lawsuit Dropped by Plaintiff"
01/05/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Tactile Medical Announces New Appointments to Board of Directors"
11/08/2021 8-K Quarterly results
Docs: "Third Quarter Revenue Increased 7% Year-Over-Year; First Nine Months Revenue Increased 14% Year-over-Year MINNEAPOLIS, MN, November 8, 2021 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of underserved chronic diseases at home, today reported financial results for the third quarter and nine months ended September 30, 2021. Third Quarter 2021 Summary: ● Total revenue increased 7% year-over-year to $52.5 million, compared to $49.1 million in third quarter 2020. ● Total revenue in third quarter 2021 included $0.9 million of revenue from the recently acquired AffloVest respiratory therapy business. ● Operating loss of $1.4 million, compared to operating income of $1.8 million in third quarter 2020. &#9..."
09/08/2021 8-K Quarterly results
08/02/2021 8-K Quarterly results
Docs: "Second Quarter Revenue Increased 45% Year-Over-Year; First Half Revenue Increased 19% Year-over-Year MINNEAPOLIS, MN, August 2, 2021 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today reported financial results for the second quarter and six months ended June 30, 2021. Second Quarter 2021 Summary: ● Total revenue increased 45% year-over-year to $51.1 million, compared to $35.1 million in second quarter 2020. ● Operating loss of $0.1 million, compared to operating loss of $8.0 million in second quarter 2020. ● Net income of $1.3 million, compared to net loss of $13.9 million in second quarter 2020. ● Adjusted EBITDA of $4.1 million, compared to Adjusted EBITDA lo..."
05/18/2021 8-K Quarterly results
05/03/2021 8-K Quarterly results
04/20/2021 8-K Quarterly results
03/12/2021 8-K Quarterly results
02/23/2021 8-K Quarterly results
01/05/2021 8-K Quarterly results
11/02/2020 8-K Quarterly results
Docs: "Third Quarter Revenue Decreased 1% Year-Over-Year; Flat Year-Over-Year on an Operational Basis First Nine Months Revenue Decreased 3% Year-over-Year; Flat Year-over-Year on an Operational Basis MINNEAPOLIS, MN, November 2, 2020 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today reported financial results for the third quarter and nine months ended September 30, 2020. Third Quarter 2020 Summary: ● Total revenue decreased 1% year-over-year, to $49.1 million, compared to $49.6 million in third quarter 2019. o Excluding the contribution to third quarter 2019 revenue related to the Company’s adoption of ASC 842, third quarter 2020 revenue reflects a flat year-over-year change on an op..."
09/03/2020 8-K Quarterly results
08/03/2020 8-K Quarterly results
05/22/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Tactile Systems Technology, Inc. Announces Appointment of Daniel L. Reuvers as President and Chief Executive Officer MINNEAPOLIS, MN, May 21, 2020 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today announced that Daniel L. Reuvers has been appointed President and Chief Executive Officer, effective June 8, 2020, to succeed Gerald R. Mattys who is retiring, as previously disclosed. Mr. Reuvers will also join the Board of Directors, effective June 8, 2020, filling a seat created by Mr. Mattys’ retirement from the Board, effective that same day. Mr. Mattys will serve as a consultant to the Company until June 2021 to ensure a seamless transition. “After a comprehensive search process which ..."
05/07/2020 8-K Quarterly results
05/04/2020 8-K Quarterly results
04/07/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Tactile Systems Technology, Inc. Reports Preliminary First Quarter 2020 Revenue Results, Withdraws Full Year 2020 Financial Outlook and Provides COVID-19 Business Update"
02/26/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy